BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6970146)

  • 1. [Studies for a sensitive radioimmunoassay of beta1-Sp1-glycoprotein (SP1) (author's transl)].
    Maeda K; Nishiyama Y; Nose Y; Murata K; Yamaguchi H; Ito M; Hayakawa S; Imaizumi H; Sugiyama Y
    Nihon Naibunpi Gakkai Zasshi; 1980 Jul; 56(7):945-61. PubMed ID: 6970146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Studies on pregnancy specific beta 1-glycoprotein (SP1) by enzymeimmunoassay (author's transl)].
    Sawaki Y; Nishiyama Y; Ito M; Hayakawa S; Imaizumi H; Nose Y; Sugiyama Y
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Jan; 34(1):53-60. PubMed ID: 7037993
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radioimmunoassay of SP1 (pregnancy-specific beta1-glycoprotein) in maternal blood and in amniotic fluid normal and pathologic pregnancies.
    Würz H; Geiger W; Künzig HJ; Jabs-Lehmann A; Bohn H; Lüben G
    J Perinat Med; 1981; 9(2):67-78. PubMed ID: 6787188
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Assessment of RIA kit for measuring pregnancy-specific beta 1 glycoprotein (SP1) and its clinical significance as a tumor marker (author's transl)].
    Tsujino D; Chida R; Sasaki Y; Someya K; Shibata K
    Radioisotopes; 1981 Sep; 30(9):502-4. PubMed ID: 6276932
    [No Abstract]   [Full Text] [Related]  

  • 5. [A study on pregnancy-specific beta 1-globulin assay (SP1-RIA) and its diagnostic application (author's transl)].
    Komishi K; Azuma S
    Horumon To Rinsho; 1982 Feb; 30(2):189-95. PubMed ID: 6282504
    [No Abstract]   [Full Text] [Related]  

  • 6. Serum SP1 and hCG beta-subunit (hCG beta) levels in choriocarcinoma, invasive mole, and hydatidiform mole--clinical significance of SP1/hCG beta ratio.
    Sakuragi N
    Gynecol Oncol; 1982 Jun; 13(3):393-8. PubMed ID: 6178652
    [No Abstract]   [Full Text] [Related]  

  • 7. Concentrations of SP1 and beta-hCG in serum and cerebrospinal fluid and concentrations of hCG in urine in patients with trophoblastic tumour.
    Soma H; Kikuchi K; Takayama M; Saegusa H; Saito T; Kashiwagi H; Sayama S
    Arch Gynecol; 1981; 230(4):321-7. PubMed ID: 6269502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The serum concentration of specific beta 1-glycoprotein in trophoblastic disease].
    Radikov N
    Akush Ginekol (Sofiia); 1989; 28(2):15-9. PubMed ID: 2548413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A radioimmunoassay of the pregnancy-specific beta1-glycoprotein (SP1).
    Sørensen S; Borggaard B; Rolff L
    Scand J Clin Lab Invest; 1977 Oct; 37(6):537-43. PubMed ID: 356177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monitoring therapy in trophoblastic diseases by radioimmunoassay of pregnancy-specific beta 1-glycoprotein and the beta subunit of human chorionic gonadotropin.
    Than GN; Csaba IF; Bohn H; Szabó DG; Szalmásy M; Menczer G
    Oncodev Biol Med; 1982; 3(4):315-23. PubMed ID: 6291007
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trophoblastic disease monitoring: Evaluation of pregnancy-specific beta 1-glycoprotein.
    O'Brien TJ; Engvall E; Schlaerth JB; Morrow CP
    Am J Obstet Gynecol; 1980 Oct; 138(3):313-20. PubMed ID: 6251725
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concentration of placental protein 10 (PP10) in maternal serum and amniotic fluid throughout normal gestation and in pregnancy complicated by fetal growth retardation.
    Würz H; Lüben G; Bohn H; Künzig HJ; Geiger W
    Arch Gynecol; 1983; 233(3):165-74. PubMed ID: 6605116
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pregnancy specific beta 1-glycoprotein and human chorionic gonadotrophin levels n amniotic fluid and maternal serum in the first half of pregnancy.
    Heikinheimo M; Seppälä M; Brock DJ
    Oncodev Biol Med; 1980 Aug; 1(1):71-6. PubMed ID: 6974343
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The serum pregnancy-specific beta 1-glycoprotein to beta-human chorionic gonadotrophin ratio as an index of prognosis in patients with choriocarcinoma.
    Sakuragi N; Ohkubo H; Yamamoto R; Shiina Y; Tanaka T; Ichinoe K; Fujimoto S
    Br J Obstet Gynaecol; 1988 Jun; 95(6):614-8. PubMed ID: 2455537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Radioimmunoassay of SP1 in obstetrics and gynecological oncology].
    Conte N; Bentivoglio G; Conio A; Diani F; Turinetto A
    Boll Soc Ital Biol Sper; 1982 Apr; 58(8):504-8. PubMed ID: 6980011
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum SP1, hPL and beta-hCG levels in trophoblastic diseases.
    Zhang WY; Yen GL
    Chin Med J (Engl); 1991 Dec; 104(12):995-8. PubMed ID: 1723674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantitative behavior of pregnancy-specific beta glycoproteins (Sp1) in the amniotic fluid in normal and pathologic pregnancies].
    Straube W; Jahns E; Leisner J; Briese V
    Zentralbl Gynakol; 1983; 105(5):270-8. PubMed ID: 6602439
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating placental proteins (hCG, SP1 and PP5) in trophoblastic disease.
    Lee JN; Salem HT; Chard T; Huang SC; Ouyang PC
    Br J Obstet Gynaecol; 1982 Jan; 89(1):69-72. PubMed ID: 6277363
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pregnancy-specific beta 1-glycoprotein in amniotic fluid in high risk late pregnancy.
    Heikinheimo M
    Oncodev Biol Med; 1980; 1(4-5):287-90. PubMed ID: 6974344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is SP1 (pregnancy specific beta 1 glycoprotein) elevated in cancer patients?
    Engvall E; Yonemoto RH
    Int J Cancer; 1979 Dec; 24(6):759-61. PubMed ID: 317495
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.